UNH
Another headache for the health giant
UnitedHealth is back in the hot seat. Shareholders have filed a derivative action against current and former leadership, accusing the company of a long-running pattern of misconduct that allegedly juiced earnings and then blew up spectacularly.
The complaint’s biggest accusations
According to the suit, UnitedHealth:
- Inflated Medicare Advantage revenue by making members look sicker than they really were
- Used automated systems to deny post-acute rehab care, with appeals supposedly succeeding 99.7% of the time
- Routed above-market payments internally to work around federal profit caps
- Misled a federal court about data firewalls during the $13 billion Change Healthcare takeover
- Sat on cybersecurity weaknesses that helped lead to the 2024 ransomware mess
That’s a lot of smoke for one filing. And if even part of it sticks, the legal bill may be the least annoying part of the story.
Why investors should care
The suit isn’t just about courtroom drama. It also says the alleged fallout helped erase more than $277 billion in shareholder value between December 2024 and August 2025, while executives allegedly sold more than $237 million of stock during the period.
UnitedHealth also gets dragged back into the same messy conversation about Medicare Advantage audits, medical-cost surprises, and whether the company’s guidance machine was too optimistic for too long. If regulators or courts start agreeing with the plaintiffs’ version of events, this could morph from a headline risk into a real financial overhang.
Big picture
For a company this big, one lawsuit usually isn’t the whole story. But this one reads like a greatest-hits album of all the things investors were already worried about — and then some. When a stock is this widely owned, trust matters almost as much as earnings.